CV Therapeutics

Cv Therapeutics

Biotechnology, 3172 Porter Dr, Palo Alto, California, 94304, United States, 201-500 Employees

cvt.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +15*********

Who is CV THERAPEUTICS

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular di...

Read More

map
  • 3172 Porter Dr, Palo Alto, California, 94304, United States Headquarters: 3172 Porter Dr, Palo Alto, California, 94304, United States
  • 1991 Date Founded: 1991
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies
  • Chris John CEO:   Chris John

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CV THERAPEUTICS

CV Therapeutics Org Chart and Mapping

VP-Level
VP-Level
Employees

Fim Jones

DDDDDDDDDDDDDDDDDDDD

Lisa Seder

Cardiovascular Specialist

Gary Parrish

Division Sales Manager

Max Nygaard

Regulatory Affairs Associate Director

Lasey Kane

Pharmaceutical Specialist

Reuben Saval

Professional Cardiovascular Account Specialist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding CV Therapeutics

Answer: CV Therapeutics's headquarters are located at 3172 Porter Dr, Palo Alto, California, 94304, United States

Answer: CV Therapeutics's phone number is +15*********

Answer: CV Therapeutics's official website is https://cvt.com

Answer: CV Therapeutics's revenue is $100 Million to $250 Million

Answer: CV Therapeutics's SIC: 2834

Answer: CV Therapeutics's NAICS: 325412

Answer: CV Therapeutics has 201-500 employees

Answer: CV Therapeutics is in Biotechnology

Answer: CV Therapeutics contact info: Phone number: +15********* Website: https://cvt.com

Answer: CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access